Skip to main content
Premium Trial:

Request an Annual Quote

Platypus Technologies Wins $2.2M DoD Contract for Nano Sensing Tech

NEW YORK (GenomeWeb News) – Platypus Technologies has been awarded a $2.2 million federal contract from the US Department of Defense to further develop molecular sensing technology, the company said this week.

The one-year contract with the Edgewood Chemical and Biological Center in Maryland expands on work completed earlier this year by Platypus under a previous contract with Edgewood.

The contract will enable Madison, Wisc.-based Platypus to further develop a sensor using its proprietary liquid crystal technology to detect molecular interactions on nanostructured surfaces. The sensors are expected to have applications in both military and civilian settings, Platypus said.

"This funding will significantly improve our ability to develop liquid crystal-based sensors and will enable us to accelerate commercialization of these sensors for both military and commercial applications," Platypus CEO Richard Schifreen said in a statement.

Platypus thus far has received more than $20 million in federal funding to develop LC-based nanotechnology products for environmental monitoring, infectious disease testing, homeland security, and assays to study cell motility.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.